RxSight, Inc. Common Stock (RXST) Stock Price

RXSTStock

$6.40−32.54%52W

Market Cap$266.20M

P/E—

PEG Ratio—

Div yield—

Beta1.10

RXST Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-37.86%

Price vs S&P 500 (4W)0.42%

VGM Score51.42

Book Value / Share (Quarterly)$6.33

P/TBV (Annual)11.72x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)40.00%

Cash Flow / Share (Quarterly)$-0.65

Price vs S&P 500 (YTD)-51.88%

Gross Margin (TTM)77.50%

Net Profit Margin (TTM)-36.80%

EPS (TTM)$-1.14

10-Day Avg Trading Volume0.83M

EPS Excl Extra (TTM)$-1.14

Revenue Growth (5Y)55.73%

EPS (Annual)$-0.95

ROI (Annual)-14.12%

Gross Margin (Annual)76.60%

Net Profit Margin (5Y Avg)-90.98%

Cash / Share (Quarterly)$5.02

Revenue Growth QoQ (YoY)0.31%

ROA (Last FY)-12.49%

Revenue Growth TTM (YoY)-13.24%

EBITD / Share (TTM)$-1.25

ROE (5Y Avg)-32.74%

Operating Margin (TTM)-43.20%

Cash Flow / Share (Annual)$-0.47

P/B Ratio1.11x

P/B Ratio (Quarterly)0.76x

Net Income / Employee (Annual)$-84,500

EV / Revenue (TTM)2.18x

Net Interest Coverage (TTM)-18.46x

ROA (TTM)-14.71%

EPS Incl Extra (Annual)$-0.95

Current Ratio (Annual)10.95x

Quick Ratio (Quarterly)3.57x

3-Month Avg Trading Volume1.00M

52-Week Price Return-32.54%

Revenue / Employee (TTM)$276,800

Tangible BV / Share (Quarterly)$4.50

P/S Ratio (Annual)2.17x

Asset Turnover (Annual)0.43x

52-Week High$13.22

Operating Margin (5Y Avg)-96.66%

EPS Excl Extra (Annual)$-0.95

CapEx CAGR (5Y)8.56%

26-Week Price Return-26.61%

Quick Ratio (Annual)9.58x

13-Week Price Return-1.42%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.07x

Enterprise Value$278.30M

Revenue / Share Growth (5Y)42.59%

Asset Turnover (TTM)0.40x

Revenue / Employee (Annual)$291,700

Inventory Turnover (Annual)1.18x

Pretax Margin (Annual)-28.91%

Cash / Share (Annual)$5.53

3-Month Return Std Dev64.32%

Gross Margin (5Y Avg)54.24%

Net Income / Employee (TTM)$-101,800

ROE (Last FY)-14.13%

Net Interest Coverage (Annual)-23.56x

EPS Basic Excl Extra (Annual)$-0.95

Receivables Turnover (TTM)5.48x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.14

Receivables Turnover (Annual)5.03x

ROI (TTM)-17.35%

P/S Ratio (TTM)2.29x

Pretax Margin (5Y Avg)-90.95%

Revenue / Share (Annual)$3.29

Tangible BV / Share (Annual)$3.18

Price vs S&P 500 (52W)-50.85%

Year-to-Date Return-39.92%

5-Day Price Return-1.73%

EPS Normalized (Annual)$-0.95

ROA (5Y Avg)-23.49%

Net Profit Margin (Annual)-28.96%

Month-to-Date Return4.16%

Cash Flow / Share (TTM)$-1.54

EBITD / Share (Annual)$-1.18

Operating Margin (Annual)-35.84%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-26.55%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.14

P/TBV (Quarterly)6.52x

P/B Ratio (Annual)1.55x

Inventory Turnover (TTM)0.92x

Pretax Margin (TTM)-36.71%

Book Value / Share (Annual)$6.68

Price vs S&P 500 (13W)-4.21%

Beta1.10x

Revenue / Share (TTM)$3.07

ROE (TTM)-17.35%

52-Week Low$4.48

vGradeB

gGradeC

mGradeD

vgmGradeC

RXST Earnings Surprise History

Q2 25-0.08est. -0.11

Q3 25-0.04est. -0.26

Q4 25-0.03est. -0.20

Q1 26-0.19est. -0.15

Q2 26-0.11est. -0.19

RXST Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.63

2.60

Industry Peers — Ophthalmic Goods(8)

Symbol	Value Score	Growth Score	Momentum Score	Price
RXSTRxSight, Inc. Common Stock	B	C	D	$6.40
ALCAlcon Inc. Ordinary Shares	C	C	C	$73.37
COOThe Cooper Companies, Inc. Common Stock	C	C	C	$73.04
BLCOBausch + Lomb Corporation	B	C	B	$17.25
WRBYWarby Parker Inc.	D	B	B	$26.00
EYENational Vision Holdings, Inc. Common Stock	B	D	C	$18.69
STAAStaar Surgical Co	D	C	D	$23.18
LUCYInnovative Eyewear, Inc. Common Stock	B	A	C	$1.07
LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27	—	—	D	$0.04

About RxSight, Inc. Common Stock

RxSight Inc is a medical technology company specializing in light adjustable intraocular lenses for cataract surgery. Its proprietary technology allows surgeons to customize and optimize patient vision outcomes post-surgery, reducing the need for corrective eyewear and improving patient satisfaction. The company manufactures light adjustable lenses and related capital equipment for the ophthalmology market.